Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
AUTOR(ES)
Gellert, M
RESUMO
Novobiocin and coumermycin are known to inhibit the replication of DNA iing of DNA catalyzed by E. coli DNA gyrase, a recently discovered enzyme that introduces negative superhelical turns into covalently circular DNA. The activity of DNA gyrase purified from a coumermycin-resistant mutant strain is resistant to both drugs. The inhibition by novobiocin of colicin E1 plasmid DNA replication in a cell-free system is partially relieved by adding resistant DNA gyrase. Both in the case of coliclls. DNA molecules which are converted to the covalently circular form in thepresence of coumermycin remain relaxed, instead of achieving their normal supercoiled conformation. We conclude that DNA gyrase controls the supercoiling of DNA in E. coli.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=431506Documentos Relacionados
- Elimination of plasmid pMG110 from Escherichia coli by novobiocin and other inhibitors of DNA gyrase.
- recF-dependent induction of recA synthesis by coumermycin, a specific inhibitor of the B subunit of DNA gyrase.
- Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
- DNA binding and antigenic specifications of DNA gyrase.
- The cleavage of DNA at phosphorothioate internucleotidic linkages by DNA gyrase.
